Weight Gain: A Possible Side Effect of All Antiretrovirals

Author:

Taramasso Lucia1,Ricci Elena2,Menzaghi Barbara3,Orofino Giancarlo4,Passerini Simone5,Madeddu Giordano6,Martinelli Canio Vito7,De Socio Giuseppe Vittorio8,Squillace Nicola9,Rusconi Stefano10,Bonfanti Paolo11,Di Biagio Antonio12,Quirino T,Bonfanti P,Ricci E,Bellacosa C,Maggi P,Calza L,Abeli C,Menzaghi B,Celesia B M,Grosso C,Stagno A,Vichi F,Mazzotta F,Martinelli C,Penco G,Cassola G,Di Biagio A,Taramasso L,Nicolini L A,Dentone C,Molteni C,Palvarini L,Scalzini A,Carenzi L,Rizzardini G,Valsecchi L,Cordier L,Rusconi S,Colombo V,Galli M,Franzetti M,De Socio G V,Mazzotta E,Parruti G,Madeddu G,Bagella P,S. Mura M,Libertone R,Antinori A,Di Giambenedetto S,Orofino G,Guastavigna M,Caramell P,

Affiliation:

1. Infectious Diseases Clinic, University of Genova (DISSAL), Policlinico Hospital San Martino, Genova, Italy

2. Epi2004, Luigi Sacco Hospital, Milano, Italy

3. Unit of Infectious Diseases, ASST della Valle Olona, Busto Arsizio Hospital, Busto Arsizio, Italy

4. Unit of Infectious Diseases, “Divisione A,” Amedeo di Savoia Hospital, Torino, Italy

5. Unit of Infectious Diseases, “I Divisione,” Luigi Sacco Hospital, Milan, Italy

6. Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy

7. Infectious and Tropical Diseases Unit, Azienda Ospedaliero Universitaria Careggi, Florence, Italy

8. Infectious Diseases Unit, Santa Maria Hospital, Perugia, Italy

9. Infectious Diseases Clinic, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy

10. Infectious Diseases, Department of Biomedical and Clinical Science Luigi Sacco, University of Milan, Milan, Italy

11. Infectious Diseases Unit, A. Manzoni Hospital, Lecco, Italy

12. Infectious Diseases Clinic, Policlinico Hospital San Martino, Genova, Italy

Abstract

Abstract Weight gain and body mass index (BMI) increase are central issues in patients living with HIV who need to minimize the risk of metabolic disease. Information collected through the SCOLTA cohort revealed significant 1-year BMI increase in patients treated with dolutegravir (P = .004), raltegravir (P = .0004), elvitegravir (P = .004), darunavir (P = .0006), and rilpivirine (P = .029). BMI gain correlated with low baseline BMI (P = .002) and older age (P = .0007) in Centers for Disease Control and Prevention stages A/B, with lower BMI (P = .005) and CD4+ T-cell count (P = .007) at enrollment in stage C.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3